Literature DB >> 169032

Studies on the Epstein-Barr Virus genome and the EBV-determined nuclear antigen in human malignant disease.

G Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 169032     DOI： 10.1101/sqb.1974.039.01.090

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  10 in total

1.  Transfection of human lymphoblastoid cells with herpes simplex viral DNA.

Authors:  G Miller; P Wertheim; G Wilson; J Robinson; J L Geelen; J van der Noordaa; A J van der Eb
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

2.  Solubilization of the Epstein-Barr virus-determined nuclear antigen and its characterization as a DNA-binding protein.

Authors:  J Luka; W Siegert; G Klein
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

3.  T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines.

Authors:  Csaba Kiss; Jun Nishikawa; Kenzo Takada; Pankaj Trivedi; George Klein; Laszlo Szekely
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

4.  Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.

Authors:  S Torsteinsdottir; M G Masucci; B Ehlin-Henriksson; C Brautbar; H Ben Bassat; G Klein; E Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution.

Authors:  G Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

Review 6.  [Factors involved in the development of human tumors using the Epstein-Barr virus as an example (author's transl)].

Authors:  W Henle
Journal:  Klin Wochenschr       Date:  1977-09-01

7.  Epstein-Barr virus-positive Burkitt's lymphoma in a German woman during pregnancy.

Authors:  G W Bornkamm; B Kaduk; G Kachel; U Schneider; K O Fresen; G Schwanitz; P Hermanek
Journal:  Blut       Date:  1980-03

8.  Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.

Authors:  M Jondal; P Gunven
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

9.  Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.

Authors:  Rajesh Ponnusamy; Ritika Khatri; Paulo B Correia; C David Wood; Erika J Mancini; Paul J Farrell; Michelle J West
Journal:  PLoS Pathog       Date:  2019-07-08       Impact factor: 6.823

10.  Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children.

Authors:  T Philip; G M Lenoir; P A Bryon; R Gerard-Marchant; G Souillet; N Philippe; F Freycon; M Brunat-Mentigny
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.